ArticleMedicine2026
Saturation effect of anion gap in predicting long-term mortality in critically ill patients with chronic obstructive pulmonary disease (COPD): A retrospective cohort study based on the MIMIC-IV database.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The relationship between anion gap (AG) and long-term mortality in intensive care unit has been widely reported, but whether this association exists in critically ill patients with chronic obstructive pulmonary disease (COPD) is still unknown. The data of this study were collected from the Medical Information Mart for Intensive Care-IV. First of all, we used the Cox regression analysis and Kaplan-Meier curves to measure the relationship between AG and 365-day mortality for critically ill patients with COPD. Next, a restricted cubic spline was used to analyze the relationship between AG and mortality. Finally, age, sex, weight, hypertension, type 2 diabetes mellitus, heart failure, myocardial infarction, and chronic kidney disease were considered for subgroup analysis. A total of 2594 eligible subjects were sampled, of which 36.24% died within 365 days of intensive care unit admission. Cox regression analysis, after adjusting for confounders, demonstrated a significant association between AG and 365-day mortality in patients with COPD (hazard ratio = 1.03, 95% confidence interval: 1.01-1.05. P < .05). Stratifying AG into quartiles revealed higher levels of AG associated with an increased risk of death (Q1: 1.00, Q2: 1.34 [1.09-1.66], Q3: 1.44 [1.17-1.78], and Q4: 1.49 [1.19-1.87]). Additionally, restricted cubic spline analysis indicated a nonlinear relationship, with a critical value of AG at 14 mmol/L. Subgroup analysis highlighted AG as a significant predictor of long-term mortality in COPD patients across different subgroups, with an interaction effect observed in the subgroup with type 2 diabetes mellitus. In critically ill patients with COPD, there was a significant positive association between AG and 365-day mortality. In addition, there is a saturation effect at AG of 14 mmol/L.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.